India to Myanmar: Gefitinib Export Trade Route

The India to Myanmar Gefitinib corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $149.0K USD. The route is dominated by KHANDELWAL LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's gefitinib manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $11.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with gefitinib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 25.8%, placing it at rank #4 among India's top gefitinib export destinations globally.

On the import side, key buyers of Indian gefitinib in Myanmar include NI LAY NAING CO.LTD.. , NI LAY NAING CO. LTD, NI LAY NAING CO LTD and 2 others. NI LAY NAING CO.LTD.. is the single largest importer with 6 shipments valued at $67.4K USD.

India's gefitinib exports to Myanmar are driven primarily by a handful of large-scale manufacturers. KHANDELWAL LABORATORIES PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — KHANDELWAL LABORATORIES PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED , GLOBELA PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $11.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as gabisof 250mg(gefitinib tablets 250mg)(pack: 1x10)(pharmaceutical formulations) and gabisof 250mg gefitinib tablets 250mg pack 1x10 pharmaceutical formulations, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NI LAY NAING CO.LTD.. is the largest importer with 6 shipments worth $67.4K USD — representing 45% of all gefitinib imports from India on this route.